Effects of toxin production in a murine model of Staphylococcus aureus keratitis

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 6, 2005, Pages 2064-2070

  Girgis, Dalia O ^a   Sloop, Gregory D ^a   Reed, Julian M ^a   O'Callaghan, Richard J ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LSU EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOLYSIN; MYELOPEROXIDASE; STAPHYLOCOCCUS ALPHA TOXIN; BACTERIAL TOXIN; PEROXIDASE; STAPHYLOCOCCAL ALPHA-TOXIN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM COLONY; BACTERIUM MUTANT; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; INOCULATION; KERATITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCAR FORMATION; SLIT LAMP; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; TOXIN SYNTHESIS; A J MOUSE; AGING; ANIMAL; BACTERIAL COUNT; BACTERIAL EYE INFECTION; CORNEA; DISEASE MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION; VIRULENCE;

AGING; ANIMALS; BACTERIAL TOXINS; COLONY COUNT, MICROBIAL; CORNEA; DISEASE MODELS, ANIMAL; EYE INFECTIONS, BACTERIAL; HEMOLYSIN PROTEINS; KERATITIS; MALE; MICE; MICE, INBRED A; PEROXIDASE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 22144435951     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0897     Document Type: Article

References (38)

1. Limberg MB. A review of bacterial keratitis and bacterial conjunctivitis. Am J Ophthalmol. 1991;112:2-9.
2. Liesgang TJ. Bacterial and fungal keratitis. In: Kaufman HE, Baron BA, McDonald MB, eds. The Cornea. Boston: Butterworth-Heinemann; 1998:159-219.
3. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology. 2000;107:1497-1502.
4. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun. 1994;62:2478-2482.
5. O'Callaghan RJ, Callegan MC, Moreau JM, et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997;65:1571-1578.
6. Booth MC, Atkuri RV, Nanda SK, Iandola JJ, Gilmore MS. Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis. Invest Ophthalmol Vis Sci. 1995;36:1828-1836.
7. Chusid MJ, Davis SD. Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense. Infect Immun. 1979;24:948-952.
8. Bhakdi S, Tranum-Jensen J. Damage to mammalian cells by proteins that form transmembrane channels. Rev Physiol Biochem Pharmacol. 1987;107:147-223.
9. Harshman S, Boquet P, Duflot E, Alouf JE, Montecucco C, Papini E. Staphylococcal alpha-toxin: a study of membrane penetration and pore formation. J Biol Chem. 1989;264:14978-14984.
10. Thelestam M, Blomqvist L. Staphylococcal alpha-toxin-recent advances. Toxicon. 1988;26:51-65.
11. Coia JE, Browning L, Haines L, Birkbeck TH, Platt DJ. Comparison of enterotoxins and haemolysins produced by methicillin-resistant (MRSA) and sensitive (MSSA) Staphylococcus aureus. J Med Microb. 1992;36:164-171.
12. Balaban N, Novick RP. Autocrine regulation of toxin synthesis by Staphylococcus aureus. Proc Nat Acad Sci USA. 1995;92:1619-1623.
13. Projan SJ, Novick RP. The molecular basis of pathogenicity. In: Crossley KB, Archer GL, eds. The Staphylococci in Human Disease. New York: Churchill Livingstone; 1999:55-82.
14. Kornblum J, Kreiswirth BN, Projan SJ, Ross H, Novick RP. Agr: a polycistronic locus regulating exoprotein synthesis in Staphylococcus aureus. In: Novick RP, ed. Molecular Biology of the Staphylococci. New York: Wiley-VCH Publishers; 1990;373-402.
15. Cheung J, Slomovic AR. Microbial etiology and predisposing factors among patients hospitalized for corneal ulceration. Can J Ophthalmol. 1995;30:251-255.
16. Gillaspy AF, Hickmon SG, Skinner RA, Thomas JR, Nelson CT, Smeltzer MS. Role of agr in pathogenesis of staphylococcal osteomyelitis. Infect Immun. 1995;63:3373-3380.
17. Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun. 1993;61:3879-3885.
18. Kielian T, Cheung A, Hickey WF. Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses. Infect Immun. 2001;69:6902-6911.
19. Girgis DO, Sloop GD, Reed JM, O'Callaghan RJ. Susceptibility of aged mice to Staphylococcus aureus keratitis. Curr Eye Res. 2004;29:269-275.
20. Hume EBH, Dajcs JJ, Moreau JM, Sloop GD, Willcox MD, O'Callaghan RJ. Staphylococcus corneal virulence in a new topical model of infection. Invest Ophthalmol Vis Sci. 2001;42:2904-2908.
21. O'Callaghan RJ, Engel LS, Hill JM. The rabbit intrastromal infection model of bacterial keratitis. In: Zak O, Sande M, eds. Handbook of Animal Models of Infection. London: Academic Press; 1999:367-374.
22. Girgis DO, Sloop GD, Reed JM, O'Callaghan RJ. A new topical model of Staphylococcus corneal infection in the mouse. Invest Ophthalmol Vis Sci. 2003;44:1591-1597.
23. O'Reilly M, DeAzavedo JCS, Kennedy S, Foster TJ. Inactivation of the alpha-hemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its hemolysis. Microb Pathogen. 1986;1:125-130.
24. Smeltzer MS, Hart ME, Iandola JJ. Phenotypic characterization of xpr, a global regulator of extracellular virulence factors in Staphylococcus aureus. Infect Immun. 1993;61:919-925.
25. Dassy B, Hogan T, Foster TJ, Fournier JM. Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus. J Gen Microbiol. 1993;139:1301-1306.
26. Hazlett LD, Moon MM, Strejc M, Berk RS. Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest Ophthalmol Vis Sci. 1987;28:1978-1985.
27. Moreau JM, Sloop GD, Engel LS, Hill JM, O'Callaghan RJ. Histopathologic studies of staphylococcal alpha-toxin: effects on rabbit corneas. Curr Eye Res. 1997;16:1221-1228.
28. Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'Callaghan RJ. Pseudomonas aeruginosa in leukopenic rabbits. Curr Eye Res. 1993;12:461-467.
29. Hobden JA, Masinick SA, Barrett RP, Hazlett LD. Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice. Infect Immun. 1997;65:2754-2758.
30. Kernacki KA, Berk RS. Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci. 1995;36:16-23.
31. Dajcs JJ, Austin MS, Sloop GD, et al. Corneal pathogenesis of Staphylococcus aureus strain Newman. Invest Ophthalmol Vis Sci. 2002;43:1109-1115.
32. Louria DB, Lavenhar MA, Kaminski T, Buse M, Kaplan M. Staphylococcal infections in aging mice. J Gerontol. 1986;41:718-722.
33. Dajcs JJ, Thibodeaux BA, Girgis DO, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus in an experimental model of keratitis. DNA Cell Biol. 2002;21:375-382.
34. Ormerod LD. Causes and management of bacterial keratitis in the elderly. Can J Ophthalmol. 1989;24:112-116.
35. Kernacki KA, Barrett RP, McClellan SA, Hazlett LD. Aging and PMN response to P. aeruginosa infection. Invest Ophthalmol Vis Sci. 2000;41:3019-3025.
36. Kunimoto DY, Sharma S, Garg P, Gopinathan U, Miller D, Rao GN. Corneal ulceration in the elderly in Hyderabad, south India. Br J Ophthalmol. 2000;84:54-59.
37. Seal DV. The effect of aging and disease on tear constituents. Trans Ophthalmol Soc UK. 1985;104:355-362.
38. Weksler ME. Senescence of the immune system. In: Dixon FJ, Fisher DW, eds. The Biology of Immunologic Disease. Sunderland, MA: Sinauer; 1983;295-306.